NDC11 10135073801
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 10135-0738-01 | 10135-0738 |
| 10135-0738-1 | 10135-0738 |
| 10135-738-01 | 10135-738 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rifabutin | RIFABUTIN | Marlex Pharmaceuticals, Inc. | df7d4103-42e4-4e4f-e053-2a95a90a8ce8 | 2025-11-18 | Warnings, Adverse reactions | 10135-738-01 10135-738 10135073801 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.